We must continue building support for legalization, but first, we need to make sure chronic pain is approved as a qualifying condition for medical cannabis.
A new poll just came out, and it confirms (yet again) that Connecticut residents strongly support legalizing cannabis and expunging criminal records for low-level offenses. Sadly, the legislature ended its regular session yesterday without voting on any of the bills that would have ended cannabis prohibition.
It's disappointing that our opponents were able to create enough uncertainty and confusion to delay our progress. However, we've come a long way — three committees advanced bills to legalize, regulate, and tax cannabis this year. If we can ramp up our efforts, we are optimistic we can get past the finish line in 2020. Please help us continue to build our coalition by making a contribution today. Please also "like" our coalition on Facebook and follow us on Twitter!
Unfortunately, your help appears to be needed on another issue. You might think it would be a no-brainer for Connecticut to approve chronic pain as a qualifying condition for the medical cannabis program, but the discussion about whether to do so has been "tabled for a future meeting" by the Board of Physicians.
Finally, please share this message with your family and friends!
Last week, the Alabama Senate overwhelmingly approved a bill that would legalize medical marijuana in the state. SB 236 would allow qualifying patients 19 and older to possess and purchase medical marijuana from authorized dispensaries.
Several conditions would qualify for medical marijuana treatment, including PTSD, chronic pain, cancer, autism, and epilepsy.
The bill will likely move to the House Judiciary Committee for consideration. Please contact your representative in the House in support of medical marijuana in Alabama today. Then, get the word out by forwarding this email to friends and family or by sharing the action link on social media.
Yesterday, the Senate Judiciary Committee approved SB 236 in a 6-2 vote. The bill would establish a medical marijuana program in Alabama and would allow patients 19 years or older to use medical marijuana to treat 33 different conditions, including autism, chronic pain, and anxiety.
Contact your lawmakers in support of SB 236 today. Medical marijuana won’t pass in Alabama without robust grassroots outreach, so please email them now.
Last week, the same committee approved a bill that would decriminalize marijuana.
Please contact your public officials today and then help get the word out by forwarding this email to friends and family. Together we can bring sensible marijuana laws to the South.
Two-thirds of Americans now live in states with compassionate laws that allow the medical use of marijuana. Meanwhile, Tennessee patients are stuck with the cruel choice of forgoing a medicine that could bring them relief, uprooting from their home state, or breaking the law to ease their suffering.
Last week, Republican lawmakers introduced twin bills that would finally allow medical cannabis in the Volunteer State. Sen. Janice Bowling and Rep. Ron Travis' Tennessee Medical Cannabis Act would provide relief to patients with around 20 medical conditions, including cancer, chronic pain, seizures, spasms, opioid addiction, and PTSD.
Unfortunately, Gov. Bill Lee (R) said he wants to "explore alternatives before we go there."
You can call Gov. Lee at 615-741-2001 or send him a tweet to respectfully let him know that patients have explored alternatives, but that medical cannabis simply works for some patients where other medicines do not. You can let him know cannabis is far safer than prescription painkillers. While 16,000 Americans die each year from opiates, none have died of a cannabis overdose.
Let your governor know Tennessee patients deserve the same medical freedom patients have in 32 other states.
And don't forget to write your lawmakers. Finally, please spread the word to other Tennesseans, so that they, too, can raise their voices for sensible and humane cannabis policies.
The Pennsylvania Health Secretary Rachel Levine announced the department will implement all of the advisory board’s recommended changes to the medical marijuana program. They include:
- Allowing patients to use whole plant, flower cannabis via vaporization.
- Rewording the qualifying condition “severe chronic or intractable pain” to delete the phrase “in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective.”
- Allowing patients to qualify if they are undergoing “addiction substitute therapy — opioid reduction.”
- Adding the following conditions to the program: cancer while in remission therapy, neurodegenerative diseases, dyskinetic and spastic movement disorders, and terminal illness.
- Eventually requiring minor patients to have recommendations from a pediatrician or other pediatric or adolescent health specialist. (This could be problematic due to the very small number of pediatricians who are recommending cannabis.)
The department will promulgate regulations with these changes on May 12, and they will then undergo legislative review.
These changes would have a major impact for Pennsylvania patients. Allowing cannabis in its flower form is crucial to affordability. And with the revised wording for severe pain, Pennsylvania will no longer steer pain patients to more dangerous medications, such as opiates.
Yesterday, Gov. Phil Murphy held a press conference to announce numerous changes to the medical marijuana program in New Jersey that will greatly improve patient access. These include:
- Approving additional qualifying conditions under a process that was begun in 2016 — including chronic pain and opioid use disorder — which will help reduce opioid dependence and overdose.
- Setting up a process to add additional businesses and remove the vertical integration requirement, which will increase competition and therefore reduce prices for patients.
- Eliminating the physician registry, so that all doctors who wish to do so can recommend medical cannabis to their patients without jumping through hoops.
- Removing the 10% THC cap imposed by regulation, because some patients need products with more THC for the most effective treatment.
In addition, the Department of Health’s report recommended additional changes, which would have to be made by the legislature. These include increasing the amount of cannabis that patients can purchase each month and allowing patients of all ages to purchase edibles if that’s their preferred delivery method.
You can read the Department of Health's full report here. MPP will continue to work with the administration as it implements these changes,
A court in Cook County, Illinois ruled last week that the Illinois Department of Public Health must add intractable pain as a qualifying condition to the state’s medical cannabis pilot program. Incredibly, the state has vowed to appeal the ruling and continue to shut pain patients out of the state program.
This is an outrage. A MoveOn.org petition is circulating that allows supporters to voice their opposition to the misguided decision by the state. If you agree the state should add intractable pain and want the state to drop its appeal plans, click here.
Patients and advocates have been working to add the condition to the state program since it went into effect in 2015. A panel of doctors and experts charged with considering new conditions voted unanimously to add pain, yet the health department refused to listen.
Even after a court reached the same conclusion, the health department continues to push back and deny access. As the nation struggles to bring a deadly opioid epidemic under control, medical cannabis should be an option for those who seek a safer alternative. Patients in Illinois should not be encouraged to seek relief from the underground market, when a regulated and tested alternative is available.
New Hampshire’s therapeutic cannabis law is finally expanding to include patients who suffer from chronic pain. HB 157 went into effect on Tuesday, adding “moderate to severe chronic pain” as a qualifying condition. This new law will allow many more Granite Staters to use cannabis as an alternative to prescribed opioids — a critically important reform for a state that is struggling to turn the tide against opiate addiction.
Until this week, patients could only qualify with a pain diagnosis if their pain was deemed to be “severe” and related to one of the specific medical conditions provided for in the law. As a result, it was much easier for medical providers to prescribe opioids than to certify patients for therapeutic cannabis. Patients who would like to apply now that the law has changed can access the updated application forms here.
For those who are waiting for the addition of post-traumatic stress disorder (PTSD), that is scheduled to take effect on August 27.
The Minnesota medical cannabis program is now accepting petitions to add qualifying conditions. Once again, MPP is teaming up with local advocate group Sensible Minnesota to petition to expand the program.
Post-traumatic stress disorder — which was added as a result of last year’s petition process — qualifies starting on Aug. 1, and the year before we were successful in efforts to add intractable pain. This year we are looking at adding several new conditions. They are: nausea, autism, dementia, Alzheimer’s disease, liver disease, and chronic pain.
If you suffer from one of these conditions, are the guardian of someone who does, or if you are a health care professional who treats one of these conditions, we want to hear from you! Please fill out this form to let us know who you are, what condition is relevant to you, and to share your story. Sensible Minnesota or MPP Foundation will be submitting letters of support along with the petitions.
The National Academies of Sciences released a report on the health impacts of marijuana Thursday, confirming the existence of medical benefits and dispelling some long-held myths about the substance.
The review of more than 10,000 scientific abstracts found, “There is conclusive or substantial evidence that cannabis or cannabinoids are effective” for the treatment of chronic pain in adults, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity.
The report also dispels several myths about the health impacts of marijuana. It found no links between smoking marijuana and the development of lung, head, or neck cancers, nor did it establish a link between marijuana use and asthma or other respiratory diseases. The respiratory problems that it did link to smoking marijuana, such as bronchitis, appear to improve after the consumer ceases their use.
According to the report, “There is no or insufficient evidence” linking marijuana use to all-cause mortality (death), deaths from overdose, or occupational accidents or injuries. It also found no substantial evidence of a link between the use of marijuana and the use of other illegal drugs. The report also does not appear to make any links between marijuana use and violent or aggressive behavior. Several of these findings were also included in the National Academies of Sciences’ previous report on marijuana, which was released in 1999.